Antioxidant activity of Hydroxytyrosol and Vitamin E reduces systemic inflammation in children with paediatric NAFLD

The rise in paediatric non-alcoholic fatty liver disease (NAFLD) is particularly alarming. We recently reported that Hydroxytyrosol (HXT) and Vitamin E (VitE) may improve oxidative stress, insulin resistance, and steatosis in children with biopsy-proven NAFLD.Here, we investigated if HXT+VitE may reduce systemic inflammation in the above-mentioned patients.This study analysed the plasma levels of IL (interleukin)-6, IL-1β, IL-10, tumour necrosis...